All Type of News
Pharmaceutical firms striving to keep afloat
The combined revenues of 70 pharmaceutical companies listed on the local bourse rose 2.6 percent to 5.6 trillion won in the first six months of this year from the previous year, according to the Korea Health Industry ...
Prior screening system for drug approval comes into effect
The prior screening system for drug approval, which had been operated as a run-in project since 2008, has been fully implemented from Nov. 8, the Korea Food and Drug Administration said yesterday.
The prior screeni...
Dongwha Pharmaceutical forges strategic tie-up with Henkel Homecare Korea
Dongwha Pharmaceutical said Wednesday that it has established a marketing and distribution partnership with Henkel Homecare Korea.
Under the deal, Dongwha will be in charge of selling Henkel’s household insecticid...
New drug pricing measure to have another grace period
The Ministry of Health and Welfare said Thursday it enacted a revision bill to legislate the government’s drug pricing measure, whose implementation will be further exteneded to Jan. 2014.
The measure, which came i...
Ildong to introduce novel weight loss drug
Ildong Pharm said Wednesday that it has entered into a marketing and supply agreement with Arena Pharmaceuticals GmbH for BELVIQ (lorcaserin HCl). BELVIQ is believed to decrease food consumption and promote satiety by...
Lee named as KRPIA vice chairmanLee Sang-suk, a former vice chairman of the Korea Hospital Association, was appointed as the third vice chairman of the Korean Research-based Pharmaceutical Industry Association...
|
Novartis Korea to receive returned goodsNovartis Korea has pledged to receive returned goods from pharmacies after a government-mandated price cut came into effect in April, according a pharmacist.
Choi Doo-ju, a c...
|
LG, Mochida announce development and licensing agreement for biosimilar
LG Life Sciences (LGLS) announced Wednesday that it has granted Japan based Mochida Pharmaceutical Co. an exclusive license to develop, register and market a biosimilar drug developed by LGLS in Korea and Japan.
Th...
Handok denies merger with Teva
Handok Pharm Tuesday denied its merger with Teva Pharmaceutical Industries, the world's leading generic drug manufacturer.
However, Handok officials said the company is still under preliminary negotiation with Teva...
Teva’s merger strains domestic pharmaceutical sector
The rumors that Teva Pharmaceuticals will acquire major stocks of Korea’s mid-tier pharmaceutical firm have strained the pharmaceutical industry here, as Teva is the world's leading generic drug manufacturer known for...
